June 4, 2020 / 11:16 AM / a month ago

BRIEF-Myriad Genetics Reports Publication Of Prospective Study Of Endopredict Test

June 4 (Reuters) - Myriad Genetics Inc:

* MYRIAD GENETICS ANNOUNCES PUBLICATION OF A PROSPECTIVE CLINICAL STUDY OF THE ENDOPREDICT® TEST IN WOMEN WITH EARLY-STAGE BREAST CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below